Turn Therapeutics (TTRX) Debt Ratio (2025 - 2026)

Turn Therapeutics (TTRX) posted quarterly Debt Ratio of 0.32 for Q1 2026.

Analysis

Turn Therapeutics (TTRX) Debt Ratio (2025 - 2026) Analysis & Trends

Turn Therapeutics' Debt Ratio history runs 1 years deep, the most recent figure standing at 0.32 for Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	0.05
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	0.05
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	0.12
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	0.47
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	0.26
10	Turn Therapeutics	302.05 Mn	302.05 Mn	-	0.72

Historic Data

Download Data